
Washington Racing to Overcome Alzheimer’s by 2025
VIDEO: Join “The Hill” in Washington, D.C. See health officials, policymakers, advocates, and medical experts offer a briefing on America’s Alzheimer’s goals and targets.

VIDEO: Join “The Hill” in Washington, D.C. See health officials, policymakers, advocates, and medical experts offer a briefing on America’s Alzheimer’s goals and targets.

Large, significant improvements in genetically-defined Alzheimer’s patients were seen in a clinical trial for tramiprosate. Learn about the important potential presented by these Phase-3 trial

Leading researchers from Johns Hopkins found that despite their very different causes and symptoms, stroke, Alzheimer’s, Parkinson’s, TBI and Huntington’s have a shared mechanism of

Years back, Accera completed clinical trials to show how diet can increase ketone levels to improve Alzheimer’s. Now, this subsidiary of Nestle Foods is creating

DRUG DEVELOPMENT: The breakthrough trial of aducanumab for Alzheimer’s recently made headline news. The FDA’s Fast Track program speeds up the development of new treatments

MAJOR ADVANCE – VIDEO & ARTICLE: A new experimental drug called “aducanumab” significantly slowed memory, thinking and cognitive decline in Alzheimer’s. It works by almost

MEMORY: In Alzheimer’s, it’s hard to find a way to boost memory. New research has uncovered a big reason why. It seems that over-boosting memory

DRUG TRIAL VIDEO & ARTICLE: See how the investigational new drug, T3D-959, elicited rapid improvement in cognitive tests in 53% of subjects with Alzheimer’s. Look

VIDEO + ARTICLE: New 3D imaging technology is uncovering Alzheimer’s hard-to-solve secrets. See how sheets of light are shedding light on curing Alzheimer’s.

VIDEO – TODAY SHOW: The 3-year A4-Trial is using solanezumab to slow memory loss caused by Alzheimer’s. See how this government-sponsored nationwide trial is making

PRODUCT OF THE WEEK: Caregivers love this pill box, as do patients and professionals. Simply fill it once a month. Roomy, simple, ingenious.


Caring for someone with Alzheimer’s is demanding enough. Now, instead of traveling for hours of infusions, families can turn to Leqembi IQLIK—a once-weekly injection approved by the FDA that makes treatment simpler, safer, and closer to home.

It is one of the most beautiful Compensations of this life thatNo man can sincerely try to help anotherWithout helping himself.

What are the early symptoms of Alzheimer’s? When to get a professional evaluation.

SHORT-TERM MEMORY lapses are obvious signs of Alzheimer’s, but other tell-tale signals begin to show much earlier. Learn how to look for semantic impairments, such as simple questions about size.

Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
No spam, only news and updates.


